outgoing Infinity Pharmaceuticals CEO Adelene Perkins and CMO Robert Ilaria

Fall­out from failed MEI merg­er con­tin­ues as In­fin­i­ty's CEO, CMO ex­it

In­fin­i­ty Phar­ma­ceu­ti­cals CEO Ade­lene Perkins and CMO Robert Ilar­ia were ter­mi­nat­ed “with­out cause” from their roles on Sept. 1 as a part of the com­pa­ny’s so-called “Au­gust re­struc­tur­ing.” CSO Stéphane Pelu­so al­so ex­it­ed the com­pa­ny.

The Cam­bridge, MA-based com­pa­ny is still grap­pling with MEI Phar­ma scrap­ping its all-stock merg­er with In­fin­i­ty on Ju­ly 24 due to poor share­hold­er sup­port. These three ex­its are de­signed to save the com­pa­ny mon­ey and are on top of its head­count re­duc­tion of 21 peo­ple — 78% of its em­ploy­ees — right af­ter the failed merg­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Senior Associate

Alexandria Real Estate Equities

Durham, NC, USA